Combinations of cancer drugs. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy9

Cell Line, Tumor Tumor Cells, Cultured Neoplastic Stem Cells Breast Prostate HCT116 Cells MCF-7 Cells HT29 Cells Lymph Nodes

Organisms3

Mice, Nude Mice, SCID Mice, Inbred BALB C

Diseases50

Neoplasms Prostatic Neoplasms Breast Neoplasms Ovarian Neoplasms Lung Neoplasms Stomach Neoplasms Colonic Neoplasms Neoplasm Metastasis Neoplasm Invasiveness Pancreatic Neoplasms Uterine Cervical Neoplasms Genetic Predisposition to Disease Carcinoma Urinary Bladder Neoplasms Carcinoma, Non-Small-Cell Lung Carcinoma, Squamous Cell Disease Progression Colorectal Neoplasms Rectal Neoplasms Neoplasm Recurrence, Local Cell Transformation, Neoplastic Endometrial Neoplasms Esophageal Neoplasms Head and Neck Neoplasms Liver Neoplasms Adenocarcinoma Mouth Neoplasms Neoplasms, Hormone-Dependent Carcinoma, Small Cell Neoplasms, Radiation-Induced Bone Neoplasms Neoplasms, Second Primary Neoplasms, Glandular and Epithelial Neovascularization, Pathologic Genital Neoplasms, Female Precancerous Conditions Skin Neoplasms Gastrointestinal Neoplasms Thyroid Neoplasms Mammary Neoplasms, Experimental Pharyngeal Neoplasms Neoplasms, Multiple Primary Kidney Neoplasms Melanoma Neoplastic Syndromes, Hereditary Carcinoma, Lobular Breast Neoplasms, Male Disease Models, Animal Occupational Diseases Neoplasms, Experimental

Chemicals and Drugs57

Antineoplastic Agents Drugs, Investigational Neoplasm Proteins Naphthoquinones Protein Kinase Inhibitors Tumor Markers, Biological Cisplatin Pyrimidines Cancer Vaccines Drug Carriers Proto-Oncogene Proteins c-abl Enzyme Inhibitors Piperazines Benzamides P-Glycoprotein Doxorubicin Receptors, Estrogen RNA, Messenger Receptor, erbB-2 Prostate-Specific Antigen DNA, Neoplasm RNA, Small Interfering Tumor Suppressor Protein p53 Fluorouracil Angiogenesis Inhibitors Tamoxifen Receptors, Progesterone Antineoplastic Agents, Phytogenic Antineoplastic Agents, Hormonal Antigens, Neoplasm Anticarcinogenic Agents Paclitaxel Receptor, Epidermal Growth Factor MicroRNAs Tumor Suppressor Proteins Antibodies, Monoclonal Deoxycytidine Antimetabolites, Antineoplastic Receptors, Androgen Taxoids RNA, Neoplasm DNA-Binding Proteins BRCA2 Protein Androgens Proto-Oncogene Proteins Antibodies, Monoclonal, Humanized Transcription Factors BRCA1 Protein Carcinogens Nuclear Proteins Estrogens Proto-Oncogene Proteins c-akt Estrogen Receptor alpha Quinazolines Androgen Antagonists Carcinoembryonic Antigen Organoplatinum Compounds

Analytical, Diagnostic and Therapeutic Techniques and Equipment71

Drug Discovery Drug Screening Assays, Antitumor Drug Design Molecular Targeted Therapy Early Detection of Cancer Drug Approval Drug Delivery Systems Clinical Trials as Topic Xenograft Model Antitumor Assays Inhibitory Concentration 50 Gene Expression Profiling Blotting, Western Drug Evaluation, Preclinical Drug Carriers Models, Biological Survival Analysis Survival Rate Prognosis Antineoplastic Combined Chemotherapy Protocols Risk Reverse Transcriptase Polymerase Chain Reaction Follow-Up Studies Retrospective Studies Registries Prospective Studies Neoplasm Staging Risk Assessment Models, Molecular Neoplasm Transplantation Disease-Free Survival Combined Modality Therapy Odds Ratio Chemotherapy, Adjuvant Transplantation, Heterologous Sensitivity and Specificity Mammography Multivariate Analysis Oligonucleotide Array Sequence Analysis Kaplan-Meier Estimate Risk Factors Questionnaires Tumor Burden SEER Program Polymerase Chain Reaction Transfection Predictive Value of Tests Logistic Models Reproducibility of Results Radiotherapy Neoplasm Grading Tissue Array Analysis Confidence Intervals Gene Knockdown Techniques Flow Cytometry Incidence Mammary Neoplasms, Experimental Drug Administration Schedule Immunoenzyme Techniques Palliative Care Mastectomy Treatment Outcome Biopsy Immunotherapy Genetic Testing Radiotherapy, Adjuvant DNA Mutational Analysis Prostatectomy Colonoscopy Disease Models, Animal Neoplasms, Experimental Immunohistochemistry

Psychiatry and Psychology1

Phenomena and Processes51

Drug Resistance, Neoplasm Gene Expression Regulation, Neoplastic Cell Proliferation Drug Resistance, Multiple Apoptosis Inhibitory Concentration 50 Cell Survival Signal Transduction Cell Cycle Dose-Response Relationship, Drug Genetic Predisposition to Disease Risk Molecular Structure Mutation Protein Binding Odds Ratio Time Factors DNA Methylation Structure-Activity Relationship Sensitivity and Specificity Genotype Cell Movement Genes, BRCA1 Down-Regulation Cell Division Polymorphism, Genetic Cell Growth Processes Promoter Regions, Genetic Protein Structure, Tertiary RNA Interference Transfection Up-Regulation Gene Silencing Genes, Tumor Suppressor Germ-Line Mutation Genes, Neoplasm Genes, p53 Postmenopause Diet Genes, BRCA2 Base Sequence Gene Expression Phenotype Phosphorylation Epithelial-Mesenchymal Transition Alleles Drug Synergism Tumor Microenvironment Epigenesis, Genetic Menopause Premenopause

Disciplines and Occupations4

Drug Discovery Drug Design Medical Oncology Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena5

Drug Approval United States Food and Drug Administration National Cancer Institute (U.S.)Quality of Life Age Distribution

Technology, Industry, Agriculture1

Humanities1

Quality of Life

Information Science8

Pharmacopoeias as Topic Survival Rate Registries Questionnaires SEER Program Base Sequence Incidence Molecular Sequence Data

Named Groups2

Survivors European Continental Ancestry Group

Health Care33

Drug Costs Fees, Pharmaceutical Clinical Trials as Topic United States Food and Drug Administration Cost Sharing Survival Analysis Survival Rate National Cancer Institute (U.S.)Risk Follow-Up Studies Retrospective Studies Registries Prospective Studies Risk Assessment Disease-Free Survival Odds Ratio Age Factors Sensitivity and Specificity Multivariate Analysis Kaplan-Meier Estimate Risk Factors Questionnaires SEER Program American Cancer Society Predictive Value of Tests Logistic Models Reproducibility of Results Confidence Intervals Incidence Palliative Care Treatment Outcome Genetic Testing Age Distribution

Geographicals4

United States Japan China Sweden

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Humanities Information Science Named Groups Health Care Geographicals

Antineoplastic Agents Neoplasms Drug Resistance, Neoplasm Drug Discovery Drug Screening Assays, Antitumor Drug Design Molecular Targeted Therapy Early Detection of Cancer Cell Line, Tumor Prostatic Neoplasms Breast Neoplasms Drug Industry Drug Approval Drug Delivery Systems Gene Expression Regulation, Neoplastic Drug Costs Fees, Pharmaceutical Clinical Trials as Topic Drugs, Investigational Mice, Nude Medical Oncology United States Food and Drug Administration Neoplasm Proteins Cell Proliferation Cost Sharing Pharmacopoeias as Topic Ovarian Neoplasms Drug Resistance, Multiple Apoptosis Xenograft Model Antitumor Assays Lung Neoplasms United States Inhibitory Concentration 50 Naphthoquinones Stomach Neoplasms Colonic Neoplasms Cell Survival Gene Expression Profiling Protein Kinase Inhibitors Tumor Markers, Biological Neoplasm Metastasis Neoplasm Invasiveness Pancreatic Neoplasms Cisplatin Signal Transduction Pyrimidines Cancer Vaccines Blotting, Western Drug Evaluation, Preclinical Cell Cycle Drug Carriers Proto-Oncogene Proteins c-abl Models, Biological Dose-Response Relationship, Drug Enzyme Inhibitors Tumor Cells, Cultured Piperazines Uterine Cervical Neoplasms Survival Analysis Genetic Predisposition to Disease Survival Rate Benzamides P-Glycoprotein Prognosis Doxorubicin Antineoplastic Combined Chemotherapy Protocols Carcinoma Urinary Bladder Neoplasms Carcinoma, Non-Small-Cell Lung Carcinoma, Squamous Cell National Cancer Institute (U.S.)Disease Progression Risk Molecular Structure Reverse Transcriptase Polymerase Chain Reaction Follow-Up Studies Colorectal Neoplasms Retrospective Studies Receptors, Estrogen Registries Prospective Studies Mutation Neoplasm Staging RNA, Messenger Survivors Receptor, erbB-2 Risk Assessment Rectal Neoplasms Models, Molecular Neoplasm Recurrence, Local Neoplasm Transplantation Disease-Free Survival Protein Binding Combined Modality Therapy Prostate-Specific Antigen DNA, Neoplasm Cell Transformation, Neoplastic Endometrial Neoplasms Odds Ratio Age Factors

No FAQ available that match "combinations of cancer drugs"